These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21963522)

  • 1. Empowering industrial research with shared biomedical vocabularies.
    Harland L; Larminie C; Sansone SA; Popa S; Marshall MS; Braxenthaler M; Cantor M; Filsell W; Forster MJ; Huang E; Matern A; Musen M; Saric J; Slater T; Wilson J; Lynch N; Wise J; Dix I
    Drug Discov Today; 2011 Nov; 16(21-22):940-7. PubMed ID: 21963522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precompetitive activity to address the biological data needs of drug discovery.
    Sidders B; Brockel C; Gutteridge A; Harland L; Jansen PG; McEwen R; Michalovich D; Seidel H; Weiss B; Williams-Jones B; Woodwark M
    Nat Rev Drug Discov; 2014 Feb; 13(2):83-4. PubMed ID: 24481293
    [No Abstract]   [Full Text] [Related]  

  • 4. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
    Thomsen MK
    Nat Rev Drug Discov; 2014 Feb; 13(2):96-7. PubMed ID: 24481301
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory science and the role of the regulator in biomedical innovation.
    Honig PK; Huang SM
    Clin Pharmacol Ther; 2012 Mar; 91(3):347-52. PubMed ID: 22343804
    [No Abstract]   [Full Text] [Related]  

  • 6. Open access chemical and clinical probes to support drug discovery.
    Edwards AM; Bountra C; Kerr DJ; Willson TM
    Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry is more alarmed about reproducibility than academia.
    Bespalov A; Barnett AG; Begley CG
    Nature; 2018 Nov; 563(7733):626. PubMed ID: 30487623
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in standards for reporting omics data.
    Taylor CF
    Curr Opin Drug Discov Devel; 2007 May; 10(3):254-63. PubMed ID: 17554851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving target assessment in biomedical research: the GOT-IT recommendations.
    Emmerich CH; Gamboa LM; Hofmann MCJ; Bonin-Andresen M; Arbach O; Schendel P; Gerlach B; Hempel K; Bespalov A; Dirnagl U; Parnham MJ
    Nat Rev Drug Discov; 2021 Jan; 20(1):64-81. PubMed ID: 33199880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accessing external innovation in drug discovery and development.
    Tufféry P
    Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informatics and standards for nanomedicine technology.
    Thomas DG; Klaessig F; Harper SL; Fritts M; Hoover MD; Gaheen S; Stokes TH; Reznik-Zellen R; Freund ET; Klemm JD; Paik DS; Baker NA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(5):511-532. PubMed ID: 21721140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergy of the whole: building a global system for clinical trials to accelerate medicines development.
    Koski G; Tobin MF; Whalen M
    Clin Ther; 2014 Oct; 36(10):1356-70. PubMed ID: 25444565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontologies in quantitative biology: a basis for comparison, integration, and discovery.
    Jensen LJ; Bork P
    PLoS Biol; 2010 May; 8(5):e1000374. PubMed ID: 20520843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future pharmaceutical research: the need to look beyond science.
    Seeger S
    Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
    Lipworth W; Doran E; Kerridge I; Day R
    Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finer nuances of clinical study agreements for research trials.
    Nayak BK
    Indian J Ophthalmol; 2008; 56(4):267-8. PubMed ID: 18579983
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development.
    Zaratin P; Comi G; Coetzee T; Ramsey K; Smith K; Thompson A; Panzara M
    Trends Pharmacol Sci; 2016 Oct; 37(10):808-810. PubMed ID: 27554755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry-academia collaborations for biomarkers.
    Asadullah K; Busch A; Gottwald M; Reinke P; Landeck L
    Nat Rev Drug Discov; 2015 Dec; 14(12):805-6. PubMed ID: 26514685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.